[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DK0977582T3 - Farmaceutiske kombinationspræparater, der indeholder erythropoietin og jernpræparater - Google Patents

Farmaceutiske kombinationspræparater, der indeholder erythropoietin og jernpræparater

Info

Publication number
DK0977582T3
DK0977582T3 DK97914258T DK97914258T DK0977582T3 DK 0977582 T3 DK0977582 T3 DK 0977582T3 DK 97914258 T DK97914258 T DK 97914258T DK 97914258 T DK97914258 T DK 97914258T DK 0977582 T3 DK0977582 T3 DK 0977582T3
Authority
DK
Denmark
Prior art keywords
pharmaceuticals containing
iron preparations
containing erythropoietin
combination pharmaceuticals
combination
Prior art date
Application number
DK97914258T
Other languages
English (en)
Inventor
Paul Lehmann
Original Assignee
Roche Diagnostics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Diagnostics Gmbh filed Critical Roche Diagnostics Gmbh
Application granted granted Critical
Publication of DK0977582T3 publication Critical patent/DK0977582T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1816—Erythropoietin [EPO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Clamps And Clips (AREA)
  • Medicinal Preparation (AREA)
DK97914258T 1997-03-18 1997-03-18 Farmaceutiske kombinationspræparater, der indeholder erythropoietin og jernpræparater DK0977582T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP1997/001343 WO1998041226A1 (de) 1997-03-18 1997-03-18 Pharmazeutische kombinationspräparate enthaltend erythropoietin und eisenpräparate

Publications (1)

Publication Number Publication Date
DK0977582T3 true DK0977582T3 (da) 2002-12-16

Family

ID=8166555

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97914258T DK0977582T3 (da) 1997-03-18 1997-03-18 Farmaceutiske kombinationspræparater, der indeholder erythropoietin og jernpræparater

Country Status (19)

Country Link
US (1) US6710028B2 (da)
EP (1) EP0977582B1 (da)
JP (1) JP2000514092A (da)
AT (1) ATE222118T1 (da)
AU (1) AU726801B2 (da)
BR (1) BR9714632A (da)
CA (1) CA2284910C (da)
CZ (1) CZ296960B6 (da)
DE (1) DE59707988D1 (da)
DK (1) DK0977582T3 (da)
ES (1) ES2180958T3 (da)
HU (1) HU226204B1 (da)
IL (2) IL131959A0 (da)
NO (1) NO324661B1 (da)
NZ (1) NZ337465A (da)
PL (1) PL187479B1 (da)
PT (1) PT977582E (da)
SI (1) SI0977582T1 (da)
WO (1) WO1998041226A1 (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7304150B1 (en) 1998-10-23 2007-12-04 Amgen Inc. Methods and compositions for the prevention and treatment of anemia
US7459435B2 (en) 2002-08-29 2008-12-02 Hoffmann-La Roche Inc. Treatment of disturbances of iron distribution
US7459436B2 (en) 2002-11-22 2008-12-02 Hoffmann-La Roche Inc. Treatment of disturbances of iron distribution
US20040198663A1 (en) * 2003-04-04 2004-10-07 Baker John E. Method of treating cardiac ischemia by using erythropoietin
WO2005000340A1 (en) * 2003-06-27 2005-01-06 Pomytkin Igor A Synergistic compositions comprising erythropoietin and succinic acid (salt)
EP1696947B1 (en) * 2003-12-19 2014-02-26 F.Hoffmann-La Roche Ag Use of erythropoietin in the treatment of disturbances of iron distribution in chronic inflammatory intestinal diseases
US20080090765A1 (en) * 2006-05-25 2008-04-17 The Trustees Of Columbia University In The City Of New York Compositions for modulating growth of embryonic and adult kidney tissue and uses for treating kidney damage
EP3381445B1 (en) 2007-11-15 2023-10-25 Amgen Inc. Aqueous formulation of antibody stablised by antioxidants for parenteral administration
EP2067752A1 (en) * 2007-12-06 2009-06-10 Nederlandse Organisatie voor toegepast- natuurwetenschappelijk onderzoek TNO Construction material
US8536106B2 (en) 2010-04-14 2013-09-17 Ecolab Usa Inc. Ferric hydroxycarboxylate as a builder
WO2011149962A1 (en) 2010-05-24 2011-12-01 The Trustees Of Columbia University In The City Of New York Mutant ngal proteins and uses thereof
WO2014081980A2 (en) 2012-11-21 2014-05-30 The Trustees Of Columbia University In The City Of New York Mutant ngal proteins and uses thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL77081A (en) 1984-12-04 1999-10-28 Genetics Inst AND sequence encoding human erythropoietin, a process for its preparation and a pharmacological preparation of human erythropoietin
US4745099A (en) 1985-02-06 1988-05-17 Chugai Seiyaku Kabushiki Kaisha Pharmaceutical composition for the treatment of the anemia of malignant tumors
KR880012235A (ko) * 1987-04-10 1988-11-26 벤자민 에프.람버트 정상 포유동물의 헤마토크릿을 증가시키는 방법
GB9001987D0 (en) * 1990-01-29 1990-03-28 Janssen Pharmaceutica Nv Improved cyclodextrin based erythropietin formulation
DE19535571A1 (de) * 1995-09-14 1997-03-20 Boehringer Mannheim Gmbh Pharmazeutische Kombinationspräparate und deren Verwendung zur Behandlung von Hämodialysepatienten
EP0885613A1 (de) * 1997-06-21 1998-12-23 Roche Diagnostics GmbH Verwendung von modifizierten Hämoglobinen zur Behandlung von Anämien und Kombinationspräparate umfassend Erythropoietin und modifiziertes Hämoglobin
DE19734293A1 (de) * 1997-08-08 1999-02-11 Boehringer Mannheim Gmbh Verwendung von pharmazeutischen Kombinationspräparaten enthaltend Erythropoietin und Eisenpräparate zur Behandlung von rheumatischen Erkrankungen
US20020065214A1 (en) * 2000-11-29 2002-05-30 Adrian Iaina Method of treating congestive heart failure
AU2002233230B2 (en) * 2000-12-20 2007-02-01 F. Hoffmann-La Roche Ag Erythropoietin conjugates

Also Published As

Publication number Publication date
IL131959A0 (en) 2001-03-19
NO324661B1 (no) 2007-11-26
WO1998041226A1 (de) 1998-09-24
DE59707988D1 (de) 2002-09-19
IL131959A (en) 2006-12-31
HUP0001409A2 (en) 2001-03-28
CZ296960B6 (cs) 2006-08-16
HU226204B1 (en) 2008-06-30
US20020094948A1 (en) 2002-07-18
NO994511L (no) 1999-09-17
ES2180958T3 (es) 2003-02-16
ATE222118T1 (de) 2002-08-15
SI0977582T1 (en) 2002-12-31
PL335858A1 (en) 2000-05-22
JP2000514092A (ja) 2000-10-24
PL187479B1 (pl) 2004-07-30
EP0977582A1 (de) 2000-02-09
NO994511D0 (no) 1999-09-17
US6710028B2 (en) 2004-03-23
PT977582E (pt) 2002-12-31
CA2284910C (en) 2003-01-28
EP0977582B1 (de) 2002-08-14
CA2284910A1 (en) 1998-09-24
AU2157297A (en) 1998-10-12
AU726801B2 (en) 2000-11-23
HUP0001409A3 (en) 2003-08-28
NZ337465A (en) 2002-04-26
BR9714632A (pt) 2000-05-23
CZ9903300A3 (cs) 2001-03-14
WO1998041226A9 (de) 1999-11-25

Similar Documents

Publication Publication Date Title
HK1001834A1 (en) Stable ascorbic acid compositions
AU4254696A (en) Novel substituted dtpa derivatives, their metal complexes, pharmaceutical compositions containing these complexes and their use in diagnosis and therapy
GEP20002331B (en) Alkylated Raphamicine Derivatives
DK0977582T3 (da) Farmaceutiske kombinationspræparater, der indeholder erythropoietin og jernpræparater
ATE104380T1 (de) Sauerstoffdelignifizierung und enzymatische behandlung.
ZA905312B (en) Combination therapy for prohylaxsis and/or treatment of benign prostatic hyperplasia
DK0851762T3 (da) Farmaceutiske kombinationspræparater, som indeholder erythropoietin og jernpræparater
NO944764L (no) Inklusjonskomplekser i vandige opplösninger av benzotiofenforbindelser med vannopplöselige cyklodekstriner og farmasöytiske formuleringer og fremgangsmåter
AU1890295A (en) Piperidines and pyrrolidines
IL87421A0 (en) Pharmaceutical compositions containing 5-amino(or substituted amino)-1,2,3-triazoles
MY102323A (en) New ribofuranuronic acid derivatives
DK0996462T3 (da) Farmaceutiske kombinationspræparater indeholdende erythropoietin og modificerede hæmoglobiner
DZ768A1 (fr) Dérivés de l'hydroxy-4-2h-1-benzothiopyran-2-one, leurs préparations et applications.
SI0736009T1 (en) N-oxides of 4-arylpiperazines and 4-arylpiperidines as antipsychotic drugs
HU912742D0 (en) T-pa pro-stabilization
GR3002381T3 (en) Use of a carboxylic acid in pharmaceutical preparations intended for topical application
TR199902305T2 (xx) Eritropoitein ve demir preperasyonları içeren farmasötik birleşimli preperasyonlar.
AU2904789A (en) Macrocyclic chelating agents and chelates thereof
SU1828577A3 (ru) Состав, стимулирующий лейкопоэз
EP0827751A3 (en) Medicinal composition containing tissue plasminogen activator and nicotinamide
BG94567A (en) Medicaments for the treatment of aids and method for its application
MX9705119A (es) Interferona modificada quimicamente.